Excellence for Life

Biotronik AG



At BIOTRONIK, we are committed to helping people with heart and blood vessel diseases live healthy, fulfilling lives. This immense responsibility motivates thousands of employees worldwide to develop new cardiovascular and endovascular medical technologies that physicians trust to save and improve patient lives. Our unique, safe and reliable products, including pacemakers, stents, implantable defibrillators and remote monitoring services, help patients in more than 100 countries.


 

BIOTRONIK is a leading global medical device company with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases. Patient well-being is our top priority and has been for more than 50 years. With thousands of employees worldwide, we are dedicated innovators who develop respected cardiac rhythm management, electrophysiology and vascular intervention solutions. Our technologies enable physicians around the world to provide patients the highest standard of care.

One of our core principles is innovating medical technology in the field of cardiology. Since our founder Max Schaldach developed the first German pacemaker in 1963, we have paved the way for pioneering innovations.

BIOTRONIK places utmost importance on research and development in order to continuously improve the diagnosis, treatment and prevention of cardiovascular and endovascular disease.

For us, excellence for life is a commitment to ensuring the highest QUALITY. We manufacture products of the highest quality to guarantee patient SAFETY at all times. We work continuously to develop innovative, unique SOLUTIONS and offer our customers excellent SERVICE. Our goal is to SAVE AND IMPROVE PATIENT LIVES.

“At BIOTRONIK, we work hard every day to make sure that our guiding principle -excellence for life- is reflected in everything we do.”

Coronary Drug-Eluting Stent System

Orsiro®

Orsiro is indicated for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease, stable angina, unstable angina, non-ST elevation myocardial infarction or documented silent ischemia due to atherosclerotic lesions in the native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm and a lesion length of ≤ 36 mm.

Download product brochure